Raksha

BACK
TO
PRODUCT
RANGE

(FOOT AND MOUTH DISEASE VACCINE BP (Vet))

Raksha FMD(Foot and Mouth Disease) vaccine is recommended for prophylactic

vaccination against Foot and Mouth Disease in cattle, buffaloes, sheep and goats.
Raksha FMD vaccine is manufactured by Indian Immunologicals with the process
know-how obtained from the Wellcome Foundation Ltd. U.K., the pioneers and world
leaders in FMD research, control and vaccine production.
COMPOSITION
Raksha FMD vaccine contains tissue culture inactivated FMD virus strains O, A, C
and Asia-1 adsorbed on Aluminium hydroxide and Saponin added as an adjuvant.
ADMINISTRATION
The vaccine vial should be kept cold until used and each vial should be well shaken
before contents are withdrawn. Syringes and needles must be sterilized before use.
The vaccine should be injected subcutaneously through an area of clean, dry skin
with precautions taken against contamination. The chest wall behind the shoulder or
the dewlap are the recommended sites for inoculation.
DOSAGE
Cattle, Buffaloes and Calves : 3 ml & Sheep and Goats : 1 ml
VACCINATION REGIMEN
Primary vaccination
: 4 months of age.
Booster
: 2 to 4 weeks after primary vaccination.
Revaccination
: Every 6 months thereafter.
Primovaccinates irrespective of age should receive two doses initially. This should be
followed
by every 6 months thereafter.
SIDE EFFECTS
Generally no significant side effects are noticed after vaccination. However, in a few
cases a small swelling may develop at the site of inoculation, which usually subsides
within a few days. The body temperature generally remains normal.

STORAGE AND TRANSPORT

The vaccine should be stored and transported between 2C and 8C. Antigenicity of
the vaccine deteriorates if the temperature is allowed to rise above this range, the
rate of deterioration depending on both temperature and time. At no stage should the
vaccine be frozen.
PRESENTATION
Raksha FMD vaccine is available in polypropylene bottles of 10 doses (30 ml) & 100
doses (300 ml).
CAUTION
Raksha FMD vaccine is thoroughly tested before issue. As subsequent handling and
administration are not controlled by the manufacturers or distributors/stockists, no
responsibility following their use can be accepted. Raksha FMD vaccine is issued
subject to this condition. Under field conditions it is extremely difficult to avoid the
accidental introduction of bacteria when withdrawing doses of Raksha FMD vaccine
from the containers. Part-used bottles of vaccine should therefore be discarded at the
end of the days operations.

Aqueous or Oil adjuvant vaccines, monovalent, bivalent, trivalent, quadrivalent

or any other valency incorporating the most relevant strains of epidemiological
significance can be manufactured as per customers choice.

Raksha Monovalent

BACK
TO
PRODUCT
RANGE

(FOOT AND MOUTH DISEASE VACCINE BP (Vet))

Raksha Monovalent FMD (Foot and Mouth Disease) vaccine is recommended for
prophylactic vaccination against Foot and Mouth Disease in cattle, buffaloes, sheep
and goats.
Raksha FMD vaccine is manufactured by Indian Immunologicals with the process
know-how obtained from the Wellcome Foundation Ltd. U.K., the pioneers and world
leaders in FMD research, control and vaccine production.
COMPOSITION
Raksha Monovalent FMD vaccine contains tissue culture inactivated FMD virus strain
O1 Manisa (monovalent) adsorbed on Aluminium hydroxide and Saponin added as
an adjuvant.
ADMINISTRATION
The vaccine vial should be kept cold until used and each vial should be well shaken
before contents are withdrawn. Syringes and needles must be sterilized before use.
The vaccine should be injected subcutaneously through an area of clean, dry skin
with precautions taken against contamination. The chest wall behind the shoulder or
the dewlap are the recommended sites for inoculation.
DOSAGE
Cattle, Buffaloes and Calves
Sheep and Goats

: 2 ml
: 1 ml

within a few days. The body temperature generally remains normal.

STORAGE AND TRANSPORT
The vaccine should be stored and transported between 2C and 8C. Antigenicity of
the vaccine deteriorates if the temperature is allowed to rise above this range, the
rate of deterioration depending on both temperature and time. At no stage should the
vaccine be frozen.
PRESENTATION
Raksha - Monovalent FMD Vaccine is available in polypropylene vials of 30 ml (15
Cattle doses and 30 Sheep doses), 100 ml (50 cattle doses and 100 sheep doses)
and 200 ml (100 cattle doses and 200 Sheep doses) .

VACCINATION REGIMEN
Primary vaccination
: 4 months of age (Cattle, Buffaloes, Sheep and Goats).
Revaccination
: Every 6 months thereafter.
Primovaccinates irrespective of age should receive two doses initially. This should be
followed by every 6 months thereafter.

CAUTION
Raksha Monovalent FMD vaccine is thoroughly tested before issue. As subsequent
handling and administration are not controlled by the manufacturers or distributors/
stockists, no responsibility following their use can be accepted. Raksha Monovalent
FMD vaccine is issued subject to this condition. Under field conditions it is extremely
difficult to avoid the accidental introduction of bacteria when withdrawing doses of
Raksha Monovalent FMD vaccine from the containers. Part-used bottles of vaccine
should therefore be discarded at the end of the days operations.

SIDE EFFECTS
Generally no significant side effects are noticed after vaccination. However, in a few
cases a small swelling may develop at the site of inoculation, which usually subsides

Aqueous or Oil adjuvant vaccines, monovalent, bivalent, trivalent, quadrivalent

or any other valency incorporating the most relevant strains of epidemiological
significance can be manufactured as per customers choice.

BACK
TO
PRODUCT
RANGE

Raksha Bivalent
(FOOT AND MOUTH DISEASE VACCINE BP (Vet.))

Raksha FMD (Foot and Mouth Disease) vaccine is recommended for prophylactic
vaccination against Foot and Mouth Disease in cattle, buffaloes, sheep and goats.
Raksha FMD vaccine is manufactured by Indian Immunologicals with the process
know-how obtained from the Wellcome Foundation Ltd. U.K., the pioneers and world
leaders in FMD research, control and vaccine production.
COMPOSITION
Raksha Bivalent FMD vaccine contains tissue culture inactivated FMD virus strain O
and A (bivalent) adsorbed on Aluminium hydroxide and Saponin added as an adjuvant.
ADMINISTRATION
The vaccine vial should be kept cold until used and each vial should be well shaken
before contents are withdrawn. Syringes and needles must be sterilized before use.
The vaccine should be injected subcutaneously through an area of clean, dry skin
with precautions taken against contamination. The chest wall behind the shoulder or
the dewlap are the recommended sites for inoculation.
DOSAGE

Cattle, Buffaloes and Calves : 3 ml

Sheep and Goats
: 1 ml

VACCINATION REGIMEN
Primary vaccination : 4 months of age (Cattle, Buffaloes, Sheep and Goats).
Revaccination
: Every 6 months thereafter.
Primovaccinates irrespective of age should receive two doses initially. This should be
followed by every 6 months thereafter.
SIDE EFFECTS
Generally no significant side effects are noticed after vaccination. However, in a few
cases a small swelling may develop at the site of inoculation, which usually subsides
within a few days. The body temperature generally remains normal.

STORAGE AND TRANSPORT

The vaccine should be stored and transported between 2C and 8C. Antigenicity of
the vaccine deteriorates if the temperature is allowed to rise above this range, the
rate of deterioration depending on both temperature and time. At no stage should the
vaccine be frozen.
PRESENTATION
Raksha Bivalent FMD vaccine is available in 300ml bottles.
CAUTION
Raksha Bivalent FMD vaccine is thoroughly tested before issue. As subsequent
handling and administration are not controlled by the manufacturers or distributors/
stockists, no responsibility following their use can be accepted. Raksha Bivalent FMD
vaccine is issued subject to this condition. Under field conditions it is extremely difficult
to avoid the accidental introduction of bacteria when withdrawing doses of Raksha
Bivalent FMD vaccine from the containers. Part-used bottles of vaccine should therefore
be discarded at the end of the days operations.

Aqueous or Oil adjuvant vaccines, monovalent, bivalent, trivalent, quadrivalent

or any other valency incorporating the most relevant strains of epidemiological
significance can be manufactured as per customers choice.

Raksha Trivalent

BACK
TO
PRODUCT
RANGE

(FOOT AND MOUTH DISEASE VACCINE BP (Vet))

Raksha Trivalent FMD (Foot and Mouth Disease) vaccine is recommended for
prophylactic vaccination against Foot and Mouth Disease in cattle, buffaloes, sheep
and goats.
Raksha FMD vaccine is manufactured by Indian Immunologicals with the process
know-how obtained from the Wellcome Foundation Ltd. U.K., the pioneers and world
leaders in FMD research, control and vaccine production.
COMPOSITION
Raksha Trivalent FMD vaccine contains tissue culture inactivated FMD virus strains
O, A and Asia-1 adsorbed on Aluminium hydroxide and Saponin added as an adjuvant.
ADMINISTRATION
The vaccine vial should be kept cold until used and each vial should be well shaken
before contents are withdrawn. Syringes and needles must be sterilized before use.
The vaccine should be injected subcutaneously through an area of clean, dry skin
with precautions taken against contamination. The chest wall behind the shoulder or
the dewlap are the recommended sites for inoculation.
DOSAGE
Cattle, Buffaloes and Calves
Sheep and Goats

: 3 ml
: 1 ml

VACCINATION REGIMEN
Primary vaccination : 4 months of age.
Booster : 2 to 4 weeks after primary vaccination.
Revaccination : Every 6 months thereafter.
Primovaccinates irrespective of age should receive two doses initially. This should be
followed by every 6 months thereafter.

SIDE EFFECTS
Generally no significant side effects are noticed after vaccination. However, in a few
cases a small swelling may develop at the site of inoculation, which usually subsides
within a few days. The body temperature generally remains normal.
STORAGE AND TRANSPORT
The vaccine should be stored and transported between 2C and 8C. Antigenicity of
the vaccine deteriorates if the temperature is allowed to rise above this range, the
rate of deterioration depending on both temperature and time. At no stage should the
vaccine be frozen.
PRESENTATION
Raksha Trivalent FMD vaccine is available in 300 ml polypropylene bottles.
CAUTION
Raksha Trivalent FMD vaccine is thoroughly tested before issue. As subsequent
handling and administration are not controlled by the manufacturers or distributors/
stockists, no responsibility following their use can be accepted. Raksha Trivalent FMD
vaccine is issued subject to this condition. Under field conditions it is extremely difficult
to avoid the accidental introduction of bacteria when withdrawing doses of Raksha
Trivalent FMD vaccine from the containers. Part-used bottles of vaccine should therefore
be discarded at the end of the days operations.

Aqueous or Oil adjuvant vaccines, monovalent, bivalent, trivalent, quadrivalent

or any other valency incorporating the most relevant strains of epidemiological
significance can be manufactured as per customers choice.

BACK
TO
PRODUCT
RANGE

Raksha-Ovac
(FOOT AND MOUTH DISEASE OIL ADJUVANT VACCINE BP (Vet))

Raksha - Ovac (FMD Oil Adjuvant vaccine) is a unique Double Emulsion Oil Adjuvant Vaccine and is recommended for prophylactic vaccination against Foot and Mouth
Disease in cattle, buffaloes, sheep, goats and pigs.
COMPOSITION
Raksha FMD Oil Adjuvant vaccine contains tissue culture virus strains O, A, C and
Asia-1 and inactivated with Aziridine compound. Mineral oil is added as an adjuvant.
ADMINISTRATION
The vaccine vial should be kept cold until used and each vial should be well shaken
before contents are withdrawn. Syringes and needles must be sterilized before use.
The vaccine should be injected subcutaneously or intramuscularly through an area of
clean, dry skin with precautions taken against contamination.
DOSAGE
Cattle, Buffaloes, Calves and Pigs
Sheep and Goats

: 2 ml
: 1 ml

VACCINATION REGIMEN
Primary vaccination
: 4 months of age (Cattle, Buffaloes, Sheep and Goats).
Primary vaccination
: 2 months of age (Pigs).
Booster
: 9 months after primary vaccination (Cattle/buffaloes/Sheep
and Goats).
Revaccination
: Every 12 months thereafter (Cattle, Buffaloes, Sheep and
Goats).
Revaccination
: Every 6 months thereafter (Pigs).
SIDE EFFECTS
As with all vaccines, hypersensitivity may occasionally occur. Adrenalin is the appropriate treatment. However, treatment is seldom required and spontaneous recovery
generally follows rapidly. In case of food animals local carcass blemish at the site of
intramuscular injection may necessitate slight trimming of the carcass. This can be
minimized by vaccinating at least two months before slaughter. Injection of mineral oil

into humans can produce serious localised reactions and special care should be taken
to avoid accidental inoculation. If it happens, medical attention should be sought at
once.
STORAGE AND TRANSPORT
The vaccine should be stored and transported between 2C and 8C. Antigenicity of
the vaccine deteriorates if the temperature is allowed to rise above this range, the
rate of deterioration depending on both temperature and time. At no stage should the
vaccine be frozen.
PRESENTATION
Raksha - OVAC vaccine is available in multiple dose bottles of 30 ml (15 doses) and
100 ml (50 doses) Packs.
CAUTION
Raksha - OVAC is thoroughly tested before issue. As subsequent handling and
administration are not controlled by the manufacturers or distributors/stockists, no
responsibility following their use can be accepted. Raksha - OVAC is issued subject
to this condition. Under field conditions it is extremely difficult to avoid the accidental
introduction of bacteria when withdrawing doses of Raksha - OVAC from the
containers. Part-used bottles of vaccine should therefore be discarded at the end of
the days operations.

FMD Oil adjuvant vaccines of monovalent, bivalent, trivalent, quadrivalent or

any other valency incorporating the most relevant strains of epidemiological
significance can be manufactured as per customers choice.

Raksha-Ovac Monovalent

BACK
TO
PRODUCT
RANGE

(MONOVALENT FOOT AND MOUTH DISEASE OIL ADJUVANT VACCINE BP (Vet))

Raksha - Ovac (FMD Oil Adjuvant vaccine) is a unique Double Emulsion Oil Adjuvant
Vaccine and is recommended for prophylactic vaccination against Foot and Mouth
Disease in cattle, buffaloes, sheep, goats and pigs.
COMPOSITION
Raksha Ovac Monovalent FMD Oil Adjuvant vaccine contains tissue culture virus
strain O (Monovalent) and inactivated with Aziridine compound. Mineral oil is added
as an adjuvant.

mineral oil into humans can produce serious localised reactions and special care
should be taken to avoid accidental inoculation. If it happens, medical attention should
be sought at once.

ADMINISTRATION
The vaccine vial should be kept cold until used and each vial should be well shaken
before contents are withdrawn. Syringes and needles must be sterilized before use.
The vaccine should be injected subcutaneously or intramuscularly through an area of
clean, dry skin with precautions taken against contamination.

STORAGE AND TRANSPORT

The vaccine should be stored and transported between 2C and 8C. Antigenicity of
the vaccine deteriorates if the temperature is allowed to rise above this range, the
rate of deterioration depending on both temperature and time. At no stage should the
vaccine be frozen.

DOSAGE
Cattle, Buffaloes, Calves, Pigs : 2 ml
Sheep and Goats : 1 ml

PRESENTATION
Raksha Ovac Monovalent vaccine is available in 30 ml, 50 ml & 100 ml (50 dose)
vials.

VACCINATION REGIMEN
Primary vaccination
: 4 months of age (Cattle, Buffaloes, Sheep and Goats).
Primary vaccination
: 2 months of age (Pigs).
Booster
: 9 months after primary vaccination (Cattle/buffaloes/Sheep
and Goats).
Revaccination
: Every 12 months thereafter (Cattle, Buffaloes, Sheep and
Goats).
Revaccination
: Every 6 months thereafter (Pigs).

CAUTION
Raksha Ovac Monovalent is thoroughly tested before issue. As subsequent handling
and administration are not controlled by the manufacturers or distributors/stockists,
no responsibility following their use can be accepted. Raksha Ovac Monovalent is
issued subject to this condition. Under field conditions it is extremely difficult to avoid
the accidental introduction of bacteria when withdrawing doses of Raksha Ovac
Monovalent from the containers. Part-used bottles of vaccine should therefore be
discarded at the end of the days operations.

SIDE EFFECTS
As with all vaccines, hypersensitivity may occasionally occur. Adrenalin is the
appropriate treatment. However, treatment is seldom required and spontaneous
recovery generally follows rapidly. In case of food animals local carcass blemish at
the site of intramuscular injection may necessitate slight trimming of the carcass. This
can be minimized by vaccinating at least two months before slaughter. Injection of

SHELF LIFE
24 months.

FMD Oil adjuvant vaccines of monovalent, bivalent, trivalent, quadrivalent or

any other combination incorporating the most relevant strains of epidemiological
significance can be manufactured as per customers choice.

Raksha-Ovac Bivalent

BACK
TO
PRODUCT
RANGE

(FOOT AND MOUTH DISEASE OIL ADJUVANT VACCINE BP (Vet))

Raksha - Ovac (FMD Oil Adjuvant vaccine) is a unique Double Emulsion Oil Adjuvant
Vaccine and is recommended for prophylactic vaccination against Foot and Mouth
Disease in cattle, buffaloes, sheep, goats and pigs.
COMPOSITION
Raksha Ovac Bivalent FMD Oil Adjuvant vaccine contains tissue culture virus strain
O and A (Bivalent) and inactivated with Aziridine compound. Mineral oil is added as
an adjuvant.

be minimized by vaccinating at least two months before slaughter. Injection of mineral

oil into humans can produce serious localised reactions and special care should be
taken to avoid accidental inoculation. If it happens, medical attention should be sought
at once.

ADMINISTRATION
The vaccine vial should be kept cold until used and each vial should be well shaken
before contents are withdrawn. Syringes and needles must be sterilized before use.
The vaccine should be injected subcutaneously or intramuscularly through an area of
clean, dry skin with precautions taken against contamination.

STORAGE AND TRANSPORT

The vaccine should be stored and transported between 2C and 8C. Antigenicity of
the vaccine deteriorates if the temperature is allowed to rise above this range, the
rate of deterioration depending on both temperature and time. At no stage should the
vaccine be frozen.

DOSAGE
Cattle, Buffaloes, Calves, Pigs : 2 ml
Sheep and Goats : 1 ml

PRESENTATION
Raksha Ovac Bivalent vaccine is available in 30 ml, 100 ml (50 dose) vials.

VACCINATION REGIMEN
Primary vaccination : 4 months of age (Cattle, Buffaloes, Sheep and Goats).
Primary vaccination : 2 months of age (Pigs).
Booster
: 9 months after primary vaccination (Cattle/buffaloes/Sheep
and Goats).
Revaccination
: Every 12 months thereafter (Cattle, Buffaloes, Sheep and
Goats).
Revaccination
: Every 6 months thereafter (Pigs).
SIDE EFFECTS
As with all vaccines, hypersensitivity may occasionally occur. Adrenalin is the
appropriate treatment. However, treatment is seldom required and spontaneous
recovery generally follows rapidly. In case of food animals local carcass blemish at the
site of intramuscular injection may necessitate slight trimming of the carcass. This can

CAUTION
Raksha Ovac Bivalent is thoroughly tested before issue. As subsequent handling and
administration are not controlled by the manufacturers or distributors/stockists, no
responsibility following their use can be accepted. Raksha Ovac Bivalent is issued
subject to this condition. Under field conditions it is extremely difficult to avoid the
accidental introduction of bacteria when withdrawing doses of Raksha Ovac Bivalent
from the containers. Part-used bottles of vaccine should therefore be discarded at the
end of the days operations.
SHELF LIFE
24 months.

FMD Oil adjuvant vaccines of monovalent, bivalent, trivalent, quadrivalent or

any other combination incorporating the most relevant strains of epidemiological
significance can be manufactured as per customers choice.

Raksha-Ovac Trivalent

BACK
TO
PRODUCT
RANGE

(FOOT AND MOUTH DISEASE OIL ADJUVANT VACCINE BP (Vet))

Raksha - Ovac (FMD Oil Adjuvant vaccine) is a unique Double Emulsion Oil Adjuvant
Vaccine and is recommended for prophylactic vaccination against Foot and Mouth
Disease in cattle, buffaloes, sheep, goats and pigs.
COMPOSITION
Raksha - Ovac Trivalent (FMD Oil Adjuvant vaccine) contains tissue culture virus strains,
O, A, Asia-1, and inactivated with Aziridine compound. Mineral oil is added as an
adjuvant.
ADMINISTRATION
The vaccine vial should be kept cold until used and each vial should be well shaken
before contents are withdrawn. Syringes and needles must be sterilized before use.
The vaccine should be injected subcutaneously or intramuscularly through an area of
clean, dry skin with precautions taken against contamination.
DOSAGE
Cattle, Buffaloes, Calves and Pigs : 2 ml
Sheep and Goats : 1 ml
VACCINATION REGIMEN
Primary vaccination : 4 months of age (Cattle, Buffaloes, Sheep and Goats).
Primary vaccination : 2 months of age (Pigs).
Booster
: 9 months after primary vaccination (Cattle/buffaloes/Sheep
and Goats).
Revaccination
: Every 12 months thereafter (Cattle, Buffaloes, Sheep and
Goats).
Revaccination
: Every 6 months thereafter (Pigs).
SIDE EFFECTS
As with all vaccines, hypersensitivity may occasionally occur. Adrenalin is the
appropriate treatment. However, treatment is seldom required and spontaneous
recovery generally follows rapidly. In case of food animals local carcass blemish at the
site of intramuscular injection may necessitate slight trimming of the carcass. This can

be minimized by vaccinating at least two months before slaughter. Injection of mineral

oil into humans can produce serious localised reactions and special care should be
taken to avoid accidental inoculation. If it happens, medical attention should be sought
at once.
STORAGE AND TRANSPORT
The vaccine should be stored and transported between 2oC and 8C. Antigenicity of
the vaccine deteriorates if the temperature is allowed to rise above this range, the
rate of deterioration depending on both temperature and time. At no stage should the
vaccine be frozen.
PRESENTATION
Raksha - Ovac Trivalent vaccine is available in 100 ml Packs.
CAUTION
Raksha - Ovac Trivalent is thoroughly tested before issue. As subsequent handling
and administration are not controlled by the manufacturers or distributors/stockists,
no responsibility following their use can be accepted. Raksha - Ovac Trivalent is issued
subject to this condition. Under field conditions it is extremely difficult to avoid the
accidental introduction of bacteria when withdrawing doses of Raksha - Ovac Trivalent
from the containers. Part-used bottles of vaccine should therefore be discarded at the
end of the days operations.

FMD Oil adjuvant vaccines of monovalent, bivalent, trivalent, quadrivalent or

any other valency incorporating the most relevant strains of epidemiological
significance can be manufactured as per customers choice.

BACK
TO
PRODUCT
RANGE

Raksha Biovac
(FOOT AND MOUTH DISEASE + HAEMORRHAGIC SEPTICAEMIA VACCINE)

Raksha - Biovac (FMD + HS Oil adjuvant vaccine) is a unique Double Emulsion Oil
Adjuvant Vaccine and is recommended for prophylactic vaccination against Foot and
Mouth Disease & Haemorrhagic Septicaemia in cattle, buffaloes.
COMPOSITION
Raksha Biovac FMD Oil Adjuvant vaccine contains FMD virus inactivated antigens
against strains ''O, A and Asia - 1'' (inactivated with Aziridine compound) and inactivated Pasteurella multocida culture (inactivated with Formaldehyde). Mineral oil is
added as an adjuvant. Thiomersal 0.01% W/V added as preservative.
ADMINISTRATION
The vaccine vial should be kept cold until used and each vial should be well shaken
before contents are withdrawn. Syringes and needles must be sterilized before use.
The vaccine should be injected intramuscularly through an area of clean, dry skin with
precautions taken against contamination, at mid neck region.
Directions
Dosage
Primary vaccination (PV)
Booster / First revaccination
Revaccination

Cattle / Buffaloes / Calves

3ml
4 months of age
9 months after PV
Annual

administration are not controlled by the manufacturers or distributors/stockists, no

responsibility following their use can be accepted. Raksha Biovac is issued subject to
this condition. Under field conditions it is extremely difficult to avoid the accidental
introduction of bacteria when withdrawing doses of Raksha Biovac from the
containers. Part-used bottles of vaccine should therefore be discarded at the end of
the day's operations. Injection of mineral oil into humans can produce serious
localized reactions and special care should be taken to avoid accidental inoculation.
If it happens, medical attention should be sought at once.

SIDE EFFECTS
Generally no significant side effects are noticed after vaccination. However, in a few
cases small swelling may develop at the site of inoculation which usually subsides
within a few days. The body temperature remains normal. In rare cases hypersensitivity may occur, immediate treatment with Antihistamine is advocated. Adrenalin is
the appropriate treatment. Accidental inoculation of oil vaccine by intravenous route
results in allergic reaction. Anti-histamine is the choice of drug incase of such allergic
reactions.

STORAGE AND TRANSPORT

The vaccine should be stored and transported between 2oC and 8o C, Antigenicity of
the vaccine deteriorates if the temperature is allowed to rise above this range, the
rate of deterioration depending on both temperature and time.
At no stage should the vaccine be frozen.

CAUTION
Raksha Biovac is thoroughly tested before issue. As subsequent handling and

PRESENTATION
Raksha Biovac vaccine is available in 30ml polypropylene vials.

NOT FOR HUMAN USE. FOR ANIMAL TREATMENT ONLY

BACK
TO
PRODUCT
RANGE

Raksharab
(Rabies Veterinary Vaccine BP (Vet))

Raksharab is recommended for immunization of dogs and other domestic

animals against rabies for prophylactic use.
COMPOSITION
Raksharab Vaccine contains inactivated rabies virus with a potency > 1.0 I.U. per
dose. The virus is propagated in BHK-21 Cell line, inactivated with an aziridine
compound and concentrated. Aluminium hydroxide is added as an adjuvant.
ADMINISTRATION
1 ml. Subcutaneously / intramuscularly.
PROPHYLACTIC USE
Age - 3 months and above.
IMMUNITY
Immunity is conferred for 36 months. However, annual vaccination is recommended in
endemic areas.

STORAGE AND TRANSPORT

Store and transport the vaccine between 2C and 8C till use. At no stage should the
vaccine be allowed to freeze.

PRECAUTIONS
Shake well before use. Vaccinate only healthy animals. Malnutrition, helminth infestation,
administration of immunosuppressive agents (like Corticosteroids, Radiation-therapy
etc.) will interfere with immune response to the vaccine.

SHELF LIFE
36 months from the date of manufacture, when stored at recommended storage
conditions.

POST VACCINATION REACTIONS

Generally no adverse reactions are noticed. Occasionally a transient, palpable nodule
may occur at the site of injection.

PRESENTATION
Single dose vial
Multidose vial containing 5 doses
Multidose vial containing 10 doses

: 1 ml
: 5 ml
: 10 ml

BACK
TO
PRODUCT
RANGE

Raksha-SP
(SHEEP POX CELL CULTURE VACCINE)

Raksha - SP (Sheep Pox) vaccine is recommended for prophylactic vaccination against

Sheep Pox sheep.
COMPOSITION
Raksha - SP vaccine contains live attenuated sheep pox virus grown on primary lamb
testicle cell culture and freeze dried. The virus is comprised of Romanian strain
which is the most effective and superior strain.
ADMINISTRATION
The vaccine presented as a freeze dried preparation in vials. Vaccine diluent vials of
50 ml are supplied for reconstituting freeze dried material. Chill the diluent prior to
reconstitution. Transfer a small aliquot of chilled diluent to vials containing the
freeze-dried preparation. Mix well to ensure uniform suspension. Transfer the
suspension to considering diluent vial and mix well. Intramuscular injection at mid
neck or thigh region.
DOSAGE
Sheep : 1 ml reconstituted vaccine.
VACCINATION REGIMEN
Suitable age for vaccination is 3 months.
It is advisable to vaccinate after lambing season or during onset of breeding season.
CAUTION
Not for human use. For animal treatment only.
Keep reconstituted vaccine on ice.
Use reconstituted vaccine immediately.
Part use of vial and storing in deep freeze or refrigerator is not recommended.
Avoid vaccination of animals in advanced stage of pregnancy.
In rare cases hypersensitivity may occur, immediate treatment with antihistaminics is
advocated.

SHELF LIFE
When stored between 2C to 8C, the vaccine retains its potency for a period of Two
years.
STORAGE AND TRANSPORT
The vaccine should be stored and transported between 2 and 8C. The diluent should
be stored in a cool and dark place.
PRESENTATION
Raksha - SP vaccine is available in 50 dose glass vials.
Diluent : 50 ml in polypropylene vials.

Raksha-HS
( Haemorrhagic Septicaemia Vaccine )

Raksha-HS is recommended for prophylactic vaccination against Haemorrhagic

Septicaemia in cattle and buffaloes.
COMPOSITION
Raksha-HS vaccine contains formalin inactivated culture of Pasteurella multocida
adjuvanted with aluminium hydroxide.
ADMINISTRATION
The vaccine vial should be thoroughly shaken before its contents are withdrawn. Only
sterile syringes and needles should be used. The vaccine should be injected
subcutaneously through an area of clean dry skin, with all precautions taken against
contamination. The recommended site for inoculation is the chest wall behind the
shoulder or the dewlap.
DOSAGE
Cattle, Buffaloes, Calves and Sheep 2 ml.
VACCINATION REGIMEN
Primary vaccination : 6months of age and above.
Revaccination
: Annually.
POST VACCINATION REACTIONS
Generally no adverse reactions are noticed. A slight swelling may appear at the site of
inoculation, which disappears quickly.
STORAGE AND TRANSPORT
The vaccine should be stored and transported between 2C and 8C. Do not allow
the vaccine to freeze.
PRESENTATION
Raksha-HS vaccine is available in polypropylene vials of 50 doses (100 ml).

BACK
TO
PRODUCT
RANGE

Raksha-BQ
( Black Quarter Vaccine )

Raksha-BQ is recommended for prophylactic vaccination against Black Quarter in

cattle and buffaloes.
COMPOSITION
Raksha-BQ vaccine contains formalin treated culture of Clostridium chauvoei
adjuvanted with aluminium hydroxide gel.
ADMINISTRATION
The vaccine vial should be thoroughly shaken before its contents are withdrawn. Only
sterile syringes and needles should be used. The vaccine should be injected
subcutaneously through an area of clean dry skin, with all precautions taken against
contamination. The recommended site for inoculation is the chest wall behind the
shoulder or the dewlap.
DOSAGE
Cattle, Buffaloes and Calves - 2 ml.
VACCINATION REGIMEN
Primary vaccination : 6months of age and above.
Revaccination
: Annually.
POST VACCINATION REACTIONS
Generally no adverse reactions are noticed. A slight swelling may appear at the site of
inoculation, which disappears quickly.
STORAGE AND TRANSPORT
The vaccine should be stored and transported between 2C and 8C. Do not allow
the vaccine to freeze.
PRESENTATION
Raksha-BQ vaccine is available in polypropylene vials of 50 doses (100 ml).

BACK
TO
PRODUCT
RANGE

Raksha-HS+BQ
( Haemorrhagic Septicaemia & Black Quarter Combined Vaccine )

Raksha-HS+BQ is recommended for prophylactic vaccination against Haemorrhagic

Septicaemia and Black Quarter in cattle and buffaloes.
COMPOSITION
Raksha-HS+BQ vaccine contains formalin inactivated cultures of Pasteurella multocida
and Clostridium chauvoei adjuvanted with aluminium hydroxide gel.
ADMINISTRATION
The vaccine vial should be thoroughly shaken before its contents are withdrawn. Only
sterile syringes and needles should be used. The vaccine should be injected
subcutaneously through an area of clean dry skin, with all precautions taken against
contamination. The recommended site for inoculation is the chest wall behind the
shoulder or the dewlap.
DOSAGE
Cattle, Buffaloes and Calves - 3 ml.
VACCINATION REGIMEN
Primary vaccination
: 6months of age and above.
Revaccination
: Annually.
POST VACCINATION REACTIONS
Generally no adverse reactions are noticed. A slight swelling may appear at the site of
inoculation, which disappears quickly.
STORAGE AND TRANSPORT
The vaccine should be stored and transported between 2C and 8C. Do not allow
the vaccine to freeze.
PRESENTATION
Raksha-HS+BQ vaccine is available in polypropylene vials of 30 doses (90 ml).

BACK
TO
PRODUCT
RANGE

BACK
TO
PRODUCT
RANGE

Rakshavac-T
(THEILERIOSIS VACCINE)

RAKSHAVAC - T Vaccine is recommended for prophylactic vaccination against

Theileriosis caused by Theileria annulata in crossbred and exotic cattle.
DESCRIPTION
Rakshavac-T is meant for prevention of Theileriosis caused by Theileria annulata in
crossbred and exotic cattle. Rakshavac-T contains live schizonts grown in lymphoblast
cell culture, attenuated by prolonged in-vitro passage. Attenuated schizonts do not
produce the clinical disease. Immunised cattle can withstand the attack of infected
ticks for a period of three years. In areas where the vaccinated animals are constantly
exposed to tick bites, the immunity is constantly boosted and hence the immunity is
conferred for life time. Where the animals are maintained in tick free condition,
revaccination every 3 years is recommended.
ADMINISTRATION
Remove the vial from liquid nitrogen container and thaw the vaccine concentrate in
lukewarm (37oC) water. Transfer the thawed vaccine concentrate using a sterile needle
and syringe to the corresponding vaccine diluent vial and mix gently. The reconstituted
vaccine should be injected subcutaneously through an area f clean dry skin with
precautions taken against contamination. The recommended site for inoculation is
midneck region.
Vaccine
Concentrate
5 Dose

Vaccine
Diluent
13.0 ml

Reconstitued
Vaccine Volume
15.0 ml

DOSAGE
Cattle and Calves - 3.0 ml.
VACCINATION REGIMEN
Cattle and calves of 2 months age and above only should be vaccinated. Vaccination
of animals in advanced stage of pregnancy should be avoided.
Immunity generally develops 6 weeks after vaccination. No other Vaccine should be
administered for a period of 8 weeks after Theileriosis Vaccine.

CAUTION
Generally no adverse reactions are noticed. A few of the vaccinated animals may
develop mild pyrexia and slight enlargement of the nearest pre-scapular lymphnode
anytime from day 8 to day 20 post vaccination.
In rare cases hypersensitivity may occur, immediate treatment with antihistaminics is
advocated.
TRANSPORT AND STORAGE
Vaccine concentrate should be transported and stored in liquid nitrogen. The vaccine
diluent should be stored in a cool and dark place.
Reconstituted vaccine should be used immediately (with one hour) and should not be
frozen for reuse.
PACKING
Vaccine concentrate
Diluent

: Vials of 5 doses.
: Vials of 13 ml

BACK
TO
PRODUCT
RANGE

Bruvax
(Brucella abortus (strain 19) vaccine, live IP (Vet))

Brucellosis is an infectious and contagious disease of zoonotic importance caused by

gram negative coccobacilli (Brucella abortus, melitensis, ovis, suis and canis). The
disease affects cattle, buffalo, pigs, sheep, goats, dogs, elk and occasionally horses.
The disease is characterized by abortion, retained placenta and to a lesser extent
orchitis and infection of accessory sex glands in males.
Bruvax is a freeze dried vaccine and is used for the prevention of brucellosis (contagious abortion) in cattle. The vaccine contains live brucella abortus strain 19 bacteria.
ditions.
DESCRIPTION
Light yellow flakes containing live Brucella abortus strain 19 bacteria in freeze dried
powder. Each dose contains not less than 40 x 109 organisms.
RECONSTITUTION
Chill the diluent prior to reconstitution. Transfer a small amount of chilled diluent to vial
containing freeze dried preparation mix well to ensure uniform suspension. Transfer
the suspension to diluent vial and mix well.
DOSAGE
Serologically negative female calves of age 4 to 8 months only should be vaccinated
with 2 ml of reconstituted vaccine.

CONTRAINDICATIONS
Male calves should not be vaccinated. Do not vaccinate pregnant animals.
PRECAUTIONS
Keep the reconstituted vaccine on ice.
Use reconstituted vaccine immediately.
Part use of the vial and restoring in deep freezer or refrigerator is not recommended.
Strictly not for human use.
Syringes, needles and gloves should be disinfected/sterilized after use.
Keep the vaccine out of the reach of children.

STORAGE & TRANSPORTATION

The vaccine must be stored and transported between 2 and 8C.

ADVERSE REACTIONS
Generally no adverse reactions are noticed. A slight swelling and mild rise in body
temperature, which may appear and disappear quickly.
The vaccine may infect human beings, particularly after accidental inoculation. Any
necessary treatment should begin without delay. It is advisable to use hand gloves
and plain protecting glasses for eyes while carrying out vaccination.

SHELF LIFE
12 months from the date of manufacture, when stored at recommended storage con-

PRESENTATION
Bruvax is available in 5 dose pack (freeze dried) along with 10 ml of sterile diluent.

ADMINISTRATION
By subcutaneous route.

BACK
TO
PRODUCT
RANGE

Bruvax Rev 1
(BRUCELLA MELITENSIS (REV 1) VACCINE (LIVE) B.P. (VET)

Bruvax Rev1 is a freeze dried vaccine and is recommended for immunization against
Brucellosis (contagious abortion) in sheep and goats.
DESCRIPTION
Bruvax Rev1, a freeze dried vaccine contains live Brucella melitensis Rev.1 strain
bacteria. Light yellow flake containing live Brucella melitensis Rev.1 strain bacteria in
lyophilized form. Each dose of vaccine contains 0.5 - 4 x 109 live organism as per B.P
(Vet).
ADMINISTRATION
The vaccine is recommended for sheep and goat @ 4 - 6 months of age, should be
vaccinated with 1 ml of reconstituted vaccine by subcutaneous route.
TRANSPORT AND STORAGE
The lyophilized vaccine must be transported and stored at 20C to 80C.
RECONSTITUTION AND METHOD OF ADMINISTRATION
The lyophilized vaccine should be reconstituted with chilled diluent provided with this
vaccine. Mix the vaccine properly in the diluent vial before inoculation. After thorough
mixing, the vaccine must be inoculated subcutaneously using sterile syringe and
separate sterile needle for each animal. The used vial should not be stored for future
use.
DOSAGE
1ml subcutaneously at mid neck region.

only. Keep the reconstituted vaccine in ice. Use reconstituted vaccine immediately.
Part use of the vial and restoring in deep freezer or refrigerator is not recommended.
PRECAUTIONS
Brucella melitensis Rev.1 vaccine has zoonotic importance. Hence it should be handled
with proper care to avoid accidental inoculation/inhalation/consumption. The used
vials along with syringe, needles and gloves must be decontaminated with
disinfectant before disposal. Keep the vaccine out of the reach of children. The
vaccine may infect human beings, particularly after accidental inoculation. Any
necessary treatment should begin without delay. It is advisable to use hand gloves
and plain protecting glasses for eyes while carrying out vaccination.
SHELF LIFE
12 months from the date of preparation when stored at recommended storage conditions (between 2oC to 8oC).
PACKAGING
Available as 5 dose, 10 dose, 20 dose, & 100 dose pack along with 5ml, 10ml, 20ml
& 100ml sterile diluent.

ADVERSE REACTION
No adverse reaction should occur following inoculation if used as directed. A single
injection should offer life long immunity, but the vaccine does not afford absolute
immunity in all animals.

DISTRUCTION OF USED CONTAINERS

The empty containers of the vaccine, used syringes and needles should be discarded
properly and carefully

CONTRAINDICATIONS / WARNINGS
Do not vaccinate the pregnant animals. Strictly not for human use. For veterinary use

CAUTION
For veterinary use only.

Raksha-ET
(Enterotoxaemia Vaccine)

Raksha-ET is recommended for prophylactic vaccination against Enterotoxaemia in

sheep and goats.
COMPOSITION
Raksha-ET vaccine contains inactivated culture of anaerobically grown Clostridium
Welchii Type D organisms. The prototoxin is converted into toxin by trypsinization.
The toxin is then rendered non-toxic by formalisation. This is then adjuvanted with
aluminium hydroxide gel.

ADMINISTRATION
The vaccine vial should be thoroughly shaken before its contents are withdrawn. Only
sterile syringes and needles should be used. The vaccine should be injected
subcutaneously through an area of clean dry skin, with all precautions taken against
contamination.
DOSAGE
Sheep and Goats - 2 ml.
VACCINATION REGIMEN
Primary vaccination
: 4 months of age and above.
Revaccination
: Annually.
POST VACCINATION REACTIONS
Generally no adverse reactions are noticed. A slight swelling may appear at the site
of inoculation, which disappears quickly.
STORAGE AND TRANSPORT
The vaccine should be stored and transported between 2C and 8C. Do not allow
the vaccine to freeze.
PRESENTATION
Raksha-ET vaccine is available in polypropylene vials of 50 doses (100 ml).

BACK
TO
PRODUCT
RANGE

BACK
TO
PRODUCT
RANGE

Raksha PPR
PESTE DES PETITS RUMINANTS (LIVING) VACCINE

COMPOSITION
Raksha PPR (Live Attenuated) vaccine containing 103 TCID50virus per dose in freezedried form.
DESCRIPTION
RAKSHA - PPR vaccine contains live attenuated Peste des petits ruminants virus
grown on Vero cell culture and freeze dried. The virus is comprised of ''Sungri 96''
strain which is the most effective and superior strain.
RAKSHA - PPR is recommended for the prophylactic vaccination against Peste des
petits ruminants in sheep & goats.
ADMINISTRATION
The vaccine is presented as freeze dried preparation in vials. Vaccine diluent vials of
25ml, 50ml & 100ml are supplied for reconstituting freeze dried material. Chill the
diluent prior to reconstitution. Draw two/five ml sterile diluent from sterile diluent vial
using sterile syringe and reconstitute with the freeze dried vial. Shake well till the
contents in the FD vials are completely dissolved. Draw the whole volume of
reconstituted mixture using sterile syringe and inject back into the sterile diluent vial,
shake gently to get virus suspension. Each ml of the reconstituted mixture contains
one immunogenic dose against PPR. The whole contents of the reconstituted
vaccine should be used immediately .
Subcutaneous injection at mid neck region is advocated through an area of clean dry
skin with all precautions taken. Sterile needles and syringes should be used for every
withdrawal.
DOSAGE
Sheep and Goat : 1 ml reconstituted vaccine.
VACCINATION REGIMEN
Suitable age for vaccination is 4 months.
CAUTION
- Weak, debilitated and infested animals should not be vaccinated.

Sheep & Goat should be dewormed prior to vaccination.

Vaccination Should be completed at least one month prior to monsoons.
Vaccination Should not be taken up in the areas of disease outbreak.
Vaccination should be checked for cold chain before reconstitution & vaccination.
Vaccination should be taken up only under the supervision of a registered veteri
nary practitioner.
- Keep reconstituted vaccine on ice.
- Use reconstituted vaccine immediately.
- Part use of vial and storing in deep freeze or refrigerator is not recommended .
- Fresh sterilized disposable needles are to be used for every sheep & goat to avoid
cross contamination.
- A maximum of 10 withdrawals should be made from reconstituted vaccine.
- Vaccination of animals in advanced stage of pregnancy is not recommended.
- In rare cases hypersensitivity may occur, immediate treatment with antihistaminic
is advocated.
Post vaccination reaction:
Generally no adverse reactions are noticed.
A few of vaccinated animals might show pyrexia and transient drop in milk yield.
Vaccination could precipitate pre-incubating diseases in rare cases.
Transportation and storage:
The vaccine should be transported at 2oC - 8oC upon arrival should be stored at
-20oC.
The diluent should be stored in a cool and dark place.
PRESENTATION
Raksha - PPR vaccine is available in 25, 50 & 100 dose glass vials. Diluent: 25ml,
50ml, & 100ml in polypropylene vials.